CRISPR-Cas9 is an RNA-guided DNA-cutting enzyme system that allows researchers to modify the genetic code of virtually any organism with a precision, speed, and affordability previously unattainable.
JUPITER, Fla. and DUBLIN, Nov. 10, 2025 (GLOBE NEWSWIRE) -- ERS Genomics Limited (‘ERS’), the CRISPR licensing company, and Dyadic Applied BioSolutions, a global biotechnology company producing ...
CRISPR functions as a programmable genetic memory system derived from bacterial immune defenses against viral infections. Guide RNA allows for rapid multiplexed targeting compared to older ...
Scientists are refining electroporation methods to improve CRISPR/Cas9 gene editing efficiency while preserving cell health. By adjusting buffer composition, pulse parameters, and delivery formats, ...
A CRISPR Therapy Just Cured A Disease From Inside The Body For The First Time. The Gene-Editing Era Officially Started Monday ...
In 2020, Jennifer Doudna, Ph.D., received the Nobel Prize in Chemistry, CRISPR-Cas9, a method for genome editing. Often referred to as “molecular scissors,” CRISPR cuts DNA at specific locations that ...
There may be a new entrant soon in the competitive race of gene editing: San Diego’s Isis Pharmaceuticals has teamed up with University of California, San Diego to produce research that demonstrates a ...
Intellia Therapeutics has reported the first-ever phase 3 results with an in vivo gene-editing therapy, hereditary angioedema ...
The MarketWatch News Department was not involved in the creation of this content. License agreement provides Jumpcode Genomics access to CRISPR gene editing technology to enhance next-generation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results